Rockville, Md.

Went public 10/3/00 at $16 per share

Filing Range:5.0 million shares @ $14 to $16

Shares Outstanding:18.6 million shares

Underwriters: Bear Stearns & Co./U.S. Bancorp Piper Jaffray/Adams Harkness & Hill Inc.

Company Counsel: Hogan & Hartson

Manager Counsel: Coudert Brothers

Auditor: Deloitte & Touche LLP

The Company:

Develops and sells software enterprising applications to support the informatics efforts of pharmaceutical and biotech companies. The company’s main product was designed for molecular biologists who conduct multiple, interrelated sequence analyses, and who are tired of trying to integrate their research data among several disjointed analytical programs. The product provides a comprehensive set of sequence analysis software tools that are seamlessly integrated, therefore they save time and avoid the annoyance of reformatting data.

Venture Backers:

FBR Technology Venture Partners LP

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 06/22/1999 1 Early Stage 4000.0

2 07/01/2000 1 Expansion 10000.0


(Data in $ millions)



Total Revenues: $10.0

Net Income: -1.3